3-iodo-alpha-methyltyrosine has been researched along with Ewing Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckervogt, V; Franzius, C; Kopka, K; Riemann, B; Schober, O; Sciuk, J; van Valen, F | 1 |
| Franzius, C; Kopka, K; Riemann, B; Schober, O; Sciuk, J; van Valen, F | 1 |
2 other study(ies) available for 3-iodo-alpha-methyltyrosine and Ewing Sarcoma
| Article | Year |
|---|---|
Characterization of 3-[123I]iodo-L-alpha-methyl tyrosine ([123I]IMT) transport into human Ewing's sarcoma cells in vitro.
Topics: Biological Transport; Bone Neoplasms; Humans; Iodine Radioisotopes; Kinetics; Methyltyrosines; Sarcoma, Ewing; Tumor Cells, Cultured | 2001 |
3-[123I]Iodo-L-alpha-methyl tyrosine transport into human fibroblasts and comparison with Ewing's sarcoma cells.
Topics: Bone Neoplasms; Cell Line; Fibroblasts; Humans; Methyltyrosines; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sarcoma, Ewing; Sensitivity and Specificity; Sodium | 2002 |